• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Emmaus Life Sciences - Articles and news items

Managed Access Program for sickle cell disease treatment, PGLG

Industry news / 26 May 2016 / Victoria White, Digital Content Producer

A Managed Access Program (MAP) for the treatment of sickle cell disease has been announced for Emmaus’ pharmaceutical grade L-glutamine treatment (PGLG)…